Tumor Markers: A Guide to Laboratory Testing
Tumor markers are substances that can be measured in blood, urine, or tissue and may be elevated in some cancers or other conditions. They are useful in specific situations, but they are not stand-alone cancer tests. This guide explains what tumor markers are, how they are used, and why results must always be interpreted by a clinician alongside imaging, biopsy, and the full clinical picture.
Key takeaways
- Tumor markers are laboratory measurements, not diagnoses; an elevated value does not by itself confirm cancer.
- Many benign conditions, medications, and normal biological variation can raise or lower tumor marker levels.
- Some markers are used mainly to monitor a known cancer over time rather than to screen for it.
- Screening with tumor markers in people without symptoms is generally not recommended because of false positives and false negatives.
- Results are most meaningful when compared with a person's earlier values and interpreted with clinical context.
What Are Tumor Markers?
Tumor markers are molecules that can be detected in blood, urine, body fluids, or tissue samples. They may be produced directly by cancer cells or by normal cells in response to a cancer or other condition. Common examples include prostate-specific antigen (PSA), carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), CA-125, CA 19-9, and CA 15-3. Some markers are proteins, others are hormones, enzymes, or genetic material.
Because these substances can also be made by healthy tissue, no tumor marker is perfectly specific to cancer. A marker may be elevated in inflammation, infection, liver or kidney disease, pregnancy, or benign growths. Likewise, some cancers do not produce measurable marker levels at all. This is why a tumor marker result is a piece of information rather than a conclusion.
How Tumor Marker Tests Are Used
In practice, tumor markers are most often used in three ways: to help monitor a known cancer during and after treatment, to help detect recurrence after treatment, and occasionally to support a diagnosis when combined with other findings. For example, AFP is used with imaging in the management of certain liver and germ cell tumors, and CA-125 may be followed in people with known ovarian cancer. In these settings, a rising or falling trend over time can be more informative than a single value.
Tumor markers are generally not used alone to screen for cancer in people without symptoms. Professional organizations advise against routine screening with most markers because many harmless conditions can cause abnormal results, leading to unnecessary procedures, while some cancers can be present with normal marker levels. When a marker is ordered, it is usually part of a broader evaluation that includes history, physical examination, imaging, and often a biopsy.
Interpreting Results and Their Limitations
Reference ranges for tumor markers vary by laboratory, by the method used, and by the population studied. A result slightly above or below a cutoff is not automatically meaningful. Clinicians look at the size of the change, the pattern over time, and how the result fits with symptoms and imaging. A single elevated value in a person with no other findings may simply be repeated or investigated with additional tests rather than treated as a diagnosis.
False positives and false negatives are both possible. Benign prostate enlargement, for instance, can raise PSA, and smoking or digestive conditions can affect CEA. Conversely, a person can have a significant cancer with a normal marker level. Because of these limitations, tumor markers should not be used to rule cancer in or out on their own, and they should not replace biopsy or imaging when those tests are indicated.
Practical Questions Before Testing
If a tumor marker test is recommended, it is reasonable to ask what question the test is meant to answer. Is it monitoring a known cancer, checking for recurrence, or helping evaluate a specific symptom? Ask how the result will change the plan, what the reference range is for the laboratory performing the test, and whether a baseline or previous value is available for comparison. These details matter more than the number alone.
It is also helpful to know that marker levels can fluctuate for reasons unrelated to cancer, including recent illness, medications, and even the time of day for some tests. Keeping a record of results over time and sharing them with the care team helps avoid unnecessary anxiety and repeated testing. Decisions about treatment should be based on the full clinical picture, not on a single laboratory value.
Frequently Asked Questions
Can a tumor marker test tell me if I have cancer?
No. Tumor marker tests cannot confirm or exclude cancer by themselves. They may be elevated in benign conditions and can be normal in people who have cancer. Diagnosis usually requires clinical evaluation, imaging, and often a biopsy.
Why would a doctor order a tumor marker test?
Tumor markers are most often used to monitor a known cancer, to check for recurrence after treatment, or to add information when a specific cancer is already suspected. They are generally not used alone to screen people without symptoms.
What does it mean if my tumor marker level is high?
A high level may be related to cancer, but it can also result from infection, inflammation, liver or kidney problems, smoking, or other benign conditions. Your clinician will interpret the result with your history, symptoms, imaging, and any previous values.
Do tumor markers replace biopsy or imaging?
No. Biopsy remains the standard way to confirm many cancers, and imaging shows where disease is located. Tumor markers are additional information and do not replace these tests when they are needed.
Sources
Ready to get tested? Study what the panel measures, note the preparation rules, and purchase through the DiagnosticTest partner when prepared.
Order Alpha-Fetoprotein (AFP) Tumor Marker TestReviewed by the DiagnosticTest Editorial Team
The DiagnosticTest review team validates panel information using trusted clinical references before it appears.